The End Brain Cancer Initiative (EBCI) is pleased to bring you this “Cover Tip” focused on Next Generation Sequencing (NGS)
If you have a solid tumor, you may benefit from an additional test called Next Generation Sequencing (NGS). NGS testing looks at the genes associated with cancer. This test may show if a gene is mutated and causing your cancer to grow. This can help your doctor make treatment decisions. One gene mutation that NGS may detect is called PTCH1-Loss of Function (LOF).
If you have had Next Generation Sequencing testing and are positive for the PTCH1-LOF mutation or if you want to learn more about NGS Testing, type into your browser: https://endbraincancer.org/endeavor
OR scan this QR Code.
Dellann Elliott Mydland
President & Board Chair
The EndBrainCancer Initiative | Chris Elliott Fund